Early Phase 1 Cytomegalovirus Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Allogeneic Hematopoietic Stem Cell Transplantation RecipientAdenovirusCytomegalovirus+2 more

Sumithira Vasu20 enrolled2 locationsNCT03665675

Recruiting

Early Phase 1

T Cell Therapy of Opportunistic Cytomegalovirus Infection

Hematopoietic Stem Cell TransplantCytomegalovirus InfectionsOpportunistic Infections

Mari Dallas20 enrolled1 locationNCT02982902

Recruiting

Early Phase 1

Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis

Cytomegalovirus RetinitisGanciclovir Eye Drops

Tianjin Medical University15 enrolled1 locationNCT05911503